Should health care money in South Africa be spent on drotrecogin alfa?
Taylor
Bettina
B
Burns
Derrick
D
van de Wal
B W
BW
MBewu
Tony
T
Keeton
G R
GR
D000890:Anti-Infective Agents / Q000191:economics*; D002986:Clinical Trials as Topic; D003422:Critical Care / Q000191:economics; D005102:Health Expenditures; D006801:Humans; D011486:Protein C / Q000191:economics*; D011994:Recombinant Proteins / Q000191:economics*; D018805:Sepsis / Q000188:drug therapy*; D013019:South Africa; D014481:United States; D014486:United States Food and Drug Administration
D000890:Anti-Infective Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated